Holen Sie sich die Stockscreener-App
8.881
3.31%
0.261
Handel nachbörslich:
8.84
-0.041
-0.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Top Novavax Shareholder Demands Company’s Sale - Barron's
Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps - Yahoo Finance
Shah Capital urges sale of Novavax amid continued vaccine sales struggles - The American Bazaar
Shah Capital Sends Letter to Novavax - MarketScreener
Novavax stock rises after major shareholder urges company sale - Investing.com
Shah Capital Urges Sale of Novavax (NVAX) Amid COVID-19 Vaccine Struggles - GuruFocus
Novavax shareholder Shah Capital urges vaccine maker to explore sale amid market struggles - The Business Journals
Novavax top investor urges sale over poor COVID shot rollout; shares rise - TradingView
Shah Capital Pushes for Novavax (NVAX) Strategic Overhaul - GuruFocus
Novavax shareholder with large stake asks company to consider selling itself - Seeking Alpha
Investor seeks sale of Novavax after poor COVID jab sales - pharmaphorum
Novavax falls as top investor urges sale over poor COVID shot rollout - TradingView
Shah Capital recommends immediate formal strategic review for sale of Novavax - MarketScreener
New US COVID guidelines add confusion, complications for Americans seeking shots - MarketScreener
Will Novavax Inc. (NVV1) stock benefit from sector leadershipTrade Ideas & AI Enhanced Trading Signals - newser.com
Is Novavax Inc. stock attractive for retirement portfoliosBond Market & Real-Time Stock Entry Alerts - newser.com
Analyzing recovery setups for Novavax Inc. investors2025 Short Interest & High Accuracy Trade Signal Alerts - newser.com
Can Novavax Inc. stock sustain market leadershipPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Intraday pattern recognizer results for Novavax Inc.Portfolio Risk Summary & Stock Market Timing Techniques - newser.com
How Novavax Inc. stock compares to market leaders2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
Tools to assess Novavax Inc.’s risk profileRecession Risk & Fast Entry Momentum Trade Alerts - newser.com
What analysts say about Novavax Inc NVV1 stockSwing Trading Watchlist & High Profit Growth Stocks - earlytimes.in
Novavax Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Novavax starts late-stage trial of COVID-19 vaccine in United States - Reuters
Novavax Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Will Novavax Inc. continue its uptrendPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Statistical indicators supporting Novavax Inc.’s strengthJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Analyzing Novavax Inc. with risk reward ratio chartsTrade Ideas & Long-Term Investment Growth Plans - newser.com
Is Novavax Inc. stock attractive after correctionWeekly Volume Report & Weekly High Conviction Ideas - newser.com
Automated trading signals detected on Novavax Inc.2025 Volatility Report & Fast Entry High Yield Tips - newser.com
Is Novavax Inc. (NVV1) stock a buy on weakness2025 Pullback Review & Scalable Portfolio Growth Methods - newser.com
Is Novavax Inc. showing signs of accumulationMarket Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
What institutional flow reveals about Novavax Inc.July 2025 Final Week & Fast Gain Stock Tips - newser.com
Novavax Inc Completes EU Marketing Authorization Transfer for Nuvaxovid - TradingView
Novavax Inc. Stock Slides 3.5%, Underperforms Peers - 富途牛牛
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
Novavax, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
Novavax (NVAX) Transfers EU Vaccine Rights to Sanofi for $25M - GuruFocus
Shah Capital Management Has $72.52 Million Stock Position in Novavax, Inc. $NVAX - MarketBeat
Novavax hands over Nuvaxovid marketing rights to Sanofi in the EU - Seeking Alpha
Novavax Continues to Deliver on Sanofi Partnership, Completion Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment - MarketScreener
Novavax Completes Transfer of Marketing Authorization for COVID-19 Vaccine in EU to Sanofi - MarketScreener
Sanofi (SNY) Gains Full EU Control of Nuvaxovid from Novavax - GuruFocus
Novavax receives $25 million milestone payment from Sanofi partnership - Investing.com
Novavax Transfers EU Vaccine Rights to Sanofi - TipRanks
$25M Milestone: Novavax Transfers Nuvaxovid EU Authorization to Sanofi; Eligible for Up to $350M - Stock Titan
Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment - Sahm
Novavax, Inc. (NVAX) Investor Outlook: Navigating a 37.67% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Novavax Inc Stock Analysis and ForecastMerger & Acquisition Updates & Free Fastest Return On Investment - earlytimes.in
Smart tools for monitoring Novavax Inc.’s price actionMarket Growth Summary & Breakout Confirmation Alerts - newser.com
Will Novavax Inc. outperform the marketStop Loss & Verified Momentum Stock Watchlist - newser.com
Can Novavax Inc. rally from current levelsTrade Volume Report & AI Powered Buy/Sell Recommendations - newser.com
Using Bollinger Bands to evaluate Novavax Inc.Analyst Downgrade & High Yield Stock Recommendations - newser.com
Will Novavax Inc. stock benefit from AI adoptionQuarterly Growth Report & High Accuracy Investment Entry Signals - newser.com
Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing AgreementHas the Bull Case Changed? - Yahoo Finance
Novavax Inc. (NVAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):